Skip to main content
logo
Lifecore Biomedical, Inc. (LFCR)
NASDAQ: LFCR · Real-Time Price · USD
5.57
-0.06 (-1.07%)
At close: Jun 8, 2026, 4:00 PM EDT
5.50
-0.07 (-1.26%)
Pre-market: Jun 9, 2026, 5:10 AM EDT

Lifecore Biomedical Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Dec '25 May '25 May '24 May '23 May '22
Market Cap
209307249172241291
Market Cap Growth
-15.41%23.21%44.86%-28.66%-17.35%-17.04%
Enterprise Value
335.19478.64413.65329.61371.76337.96
Last Close Price
5.578.186.725.627.949.87
PE Ratio
---17.03--
Forward PE
---25.55--
PEG Ratio
-20.2520.2520.2520.2520.25
PS Ratio
1.61-1.931.342.332.62
PB Ratio
6.13-21.59186.2415.18-56.923.32
P/TBV Ratio
-7.31-21.59175.1418.21-56.233.31
P/OCF Ratio
16.63--668.34--
EV/Sales Ratio
2.59-3.212.573.603.04
EV/EBITDA Ratio
40.67----53.90
Debt / Equity Ratio
-5.20-9.9595.0610.93-26.190.54
Debt / EBITDA Ratio
10.53----23.96
Debt / FCF Ratio
23.26-----
Net Debt / Equity Ratio
-4.46-8.7288.8710.19-22.111.70
Net Debt / EBITDA Ratio
9.05--12.88-129.51-10.8523.80
Net Debt / FCF Ratio
19.99--8.72-6.35-2.40-2.84
Asset Turnover
0.5500.520.510.390.29
Inventory Turnover
3.0602.452.141.961.46
Quick Ratio
2.332.181.721.021.220.22
Current Ratio
3.793.492.842.082.390.66
Return on Equity (ROE)
5.38%0.00%-612.08%263.40%-153.69%-10.65%
Return on Assets (ROA)
2.52%0.00%-6.98%-3.55%-8.21%-3.80%
Return on Invested Capital (ROIC)
3.07%0.00%-8.45%-4.42%-8.55%-3.78%
Return on Capital Employed (ROCE)
2.82%0.00%-8.13%-4.12%-13.95%-4.72%
Earnings Yield
-0.00%-5.87%--
FCF Yield
2.98%0.00%----
Buyback Yield / Dilution
-1.63%-7.64%5.02%-22.37%-1.67%-0.59%
Total Shareholder Return
-1.63%-7.64%5.02%-22.37%-1.67%-0.59%
SEC Filings: 10-K · 10-Q